Jooss K - Search Results

1

Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy.

Hamel Y, Blake N, Gabrielsson S, Haigh T, Jooss K, Martinache C, Caillat-Zucman S, Rickinson AB, Hacein-Bey S, Fischer A, Cavazzana-Calvo M. Hamel Y, et al. Among authors: jooss k. Hum Gene Ther. 2002 May 1;13(7):855-66. doi: 10.1089/10430340252899028. Hum Gene Ther. 2002. PMID: 11975851

2

Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.

Sarukhan A, Soudais C, Danos O, Jooss K. Sarukhan A, et al. Among authors: jooss k. J Gene Med. 2001 May-Jun;3(3):260-70. doi: 10.1002/jgm.175. J Gene Med. 2001. PMID: 11437331

3

Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Yang Y, et al. Among authors: jooss ku. Gene Ther. 1996 Feb;3(2):137-44. Gene Ther. 1996. PMID: 8867861

4

Tolerance induction to self antigens by peripheral dendritic cells.

Lambolez F, Jooss K, Vasseur F, Sarukhan A. Lambolez F, et al. Among authors: jooss k. Eur J Immunol. 2002 Sep;32(9):2588-97. doi: 10.1002/1521-4141(200209)32:9<2588::AID-IMMU2588>3.0.CO;2-1. Eur J Immunol. 2002. PMID: 12207343 Free article.

5

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

Jooss K, Yang Y, Wilson JM. Jooss K, et al. Hum Gene Ther. 1996 Aug 20;7(13):1555-66. doi: 10.1089/hum.1996.7.13-1555. Hum Gene Ther. 1996. PMID: 8864756

6

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.

Sarukhan A, Camugli S, Gjata B, von Boehmer H, Danos O, Jooss K. Sarukhan A, et al. Among authors: jooss k. J Virol. 2001 Jan;75(1):269-77. doi: 10.1128/JVI.75.1.269-277.2001. J Virol. 2001. PMID: 11119597 Free PMC article.

7

Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.

Jooss K, Chirmule N. Jooss K, et al. Gene Ther. 2003 Jun;10(11):955-63. doi: 10.1038/sj.gt.3302037. Gene Ther. 2003. PMID: 12756416 Review.

8

Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.

Ganesh S, Gonzalez-Edick M, Gibbons D, Waugh J, Van Roey M, Jooss K. Ganesh S, et al. Among authors: jooss k. Hum Gene Ther. 2009 Oct;20(10):1201-13. doi: 10.1089/hum.2009.045. Hum Gene Ther. 2009. PMID: 19572803

9

Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.

Jooss K, Turka LA, Wilson JM. Jooss K, et al. Gene Ther. 1998 Mar;5(3):309-19. doi: 10.1038/sj.gt.3300595. Gene Ther. 1998. PMID: 9614550

10

Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.

Harding TC, Dickinson PJ, Roberts BN, Yendluri S, Gonzalez-Edick M, Lecouteur RA, Jooss KU. Harding TC, et al. Hum Gene Ther. 2006 Aug;17(8):807-20. doi: 10.1089/hum.2006.17.807. Hum Gene Ther. 2006. PMID: 16942441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters